Physician

John Thomas Phelan, M.D.

According to 2025 Medicare claims, John Phelan, M.D. (NPI: 1467408609) practices hematology/oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Rensselaer, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12180-2450.

Phelan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 584 traditional Medicare patients, billed 93,273 HCPCS/CPT codes, and received $1,445,419 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,188 prescription claims across 181 beneficiaries totaling $2,882,332 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 16 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,103,383 to $2,882,332. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $5,076 to $891.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,126	157,954	$1,359,857
2016	1,102	129,284	$1,545,822
2017	1,060	122,330	$1,741,246
2018	918	123,465	$1,693,724
2019	827	137,919	$1,686,785
2020	925	123,581	$1,817,134
2021	751	135,331	$1,656,682
2022	585	42,561	$656,765
2023	567	88,396	$1,221,285
2024	584	93,273	$1,445,419

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	209	956	$1,103,383
2016	219	1,087	$1,221,026
2017	224	1,067	$1,330,657
2018	224	1,359	$1,716,053
2019	214	1,433	$2,085,472
2020	219	1,387	$2,510,568
2021	216	1,322	$2,502,014
2022	189	1,245	$3,117,648
2023	184	1,260	$3,061,054
2024	181	1,188	$2,882,332

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	55	$4,484
2016	N/R	N/R	N/R
2017	N/R	95	$11,525
2018	N/R	146	$21,727
2019	N/R	11	$420
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	16	$3,999
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	318	595	$13
80053	Blood test, comprehensive group of blood chemicals	401	860	$10
36415	Insertion of needle into vein for collection of blood sample	411	926	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	413	1,051	$8
83615	Lactate dehydrogenase (enzyme) level	360	698	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	43	1,290	$641,020
Imbruvica	Ibrutinib	38	1,064	$472,986
Lenalidomide	Lenalidomide	25	662	$348,475
Jakafi	Ruxolitinib Phosphate	12	360	$305,158
Bosulif	Bosutinib	12	360	$236,955

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for John Thomas Phelan, M.D.?

Tedicare shows public-source Medicare data for John Thomas Phelan, M.D. (NPI 1467408609), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Thomas Phelan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Thomas Phelan, M.D.?

John Thomas Phelan, M.D. is linked to NEW YORK ONCOLOGY HEMATOLOGY, P.C. (billing NPI 1609863448) in the available physician profile data.

Does John Thomas Phelan, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.